Trials / Completed
CompletedNCT04089748
Basal Tumours in Bladder Cancer, Response to chemoTherapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 293 (actual)
- Sponsor
- University Hospital, Rouen · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Determine the sensitivity/resistance to chemotherapy of the various subgroups of muscle-invasive bladder cancers, including the basal subgroup (about 25% of these tumours) according to 4 different classifications based on molecular or immunohistochemical classifiers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | neoadjuvant chemotherapy with cisplatine | Tumors from patient having muscle invasive bladder cancer who benefit from neoadjuvant chemotherapy with cisplatine |
Timeline
- Start date
- 2019-02-27
- Primary completion
- 2019-04-29
- Completion
- 2019-04-29
- First posted
- 2019-09-13
- Last updated
- 2025-06-06
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04089748. Inclusion in this directory is not an endorsement.